We are live on ! Find out more
HA

Hamel Associates Portfolio holdings

AUM $363M
1-Year Est. Return 24.39%
This Fund
S&P 500
This Quarter Est. Return
+1.52%
1 Year Est. Return
+24.39%
3 Year Est. Return
+50.64%
5 Year Est. Return
+68.03%
10 Year Est. Return
+174.56%
AUM
$295M
AUM Growth
+$1.04M
Cap. Flow
+$1.16M
Cap. Flow %
0.39%
Top 10 Hldgs %
40.24%
Holding
82
New
11
Increased
15
Reduced
41
Closed
1

Sector Composition

Rank Sector Weight
1 Consumer Staples 13.89%
2 Technology 11.81%
3 Healthcare 11.44%
4 Financials 10.06%
5 Industrials 9.8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IBTH icon
76
iShares iBonds Dec 2027 Term Treasury ETF
IBTH
$2.25B
$235K 0.08%
+10,469
New +$235K
IBTG icon
77
iShares iBonds Dec 2026 Term Treasury ETF
IBTG
$2.24B
$234K 0.08%
+10,210
New +$234K
IBTF
78
DELISTED
iShares iBonds Dec 2025 Term Treasury ETF
IBTF
$234K 0.08%
+9,998
New +$233K
JEPQ icon
79
JPMorgan Nasdaq Equity Premium Income ETF
JEPQ
$39.3B
$231K 0.08%
+4,243
New +$219K
CSCO icon
80
Cisco
CSCO
$457B
$231K 0.08%
3,325
-505
-13% -$31K
GEV icon
81
GE Vernova
GEV
$264B
$210K 0.07%
+396
New +$165K
BMY icon
82
Bristol-Myers Squibb
BMY
$133B
-3,602
Closed -$220K

Similar funds

Hamel Associates's Q2 2025 Portfolio in Review

As of Q2 2025, Hamel Associates held 82 positions worth $295M, up 0.35% from $294M the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Hamel Associates's Q2 2025 filing shows 11 new, 15 increased, 41 reduced and 1 closed positions. Its largest new stake was Huntington Ingalls Industries: 3,366 shares worth $813K. The largest sale was Nike, an estimated $3.7M.

By sector, the portfolio is most concentrated in Consumer Staples at 14% of assets, down from 15% a quarter earlier, followed by Technology and Healthcare.

  • Hamel Associates's largest Q2 2025 buy was Huntington Ingalls Industries: 3,366 shares worth $813K.
  • Hamel Associates added most to Schwab International Dividend Equity ETF in Q2 2025, an estimated $10.2M increase.
  • Hamel Associates's biggest Q2 2025 reduction was Nike, cutting an estimated $3.7M.
  • Hamel Associates fully exited Bristol-Myers Squibb in Q2 2025, selling an estimated $220K.
  • Hamel Associates's ten largest holdings make up 40% of its $295M portfolio in Q2 2025.
  • Hamel Associates opened 11 new positions and closed 1 in Q2 2025.
  • Hamel Associates's portfolio value rose 0.35% quarter-over-quarter to $295M.

Based on Hamel Associates's 13F filing for Q2 2025, filed 13 Aug 2025.